Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
2002 4
2003 2
2004 4
2005 2
2006 3
2007 3
2008 4
2009 5
2010 5
2011 9
2012 8
2013 11
2014 3
2015 5
2016 8
2017 7
2018 6
2019 10
2020 8
2021 3
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K, Hamada N, Tokunaga S, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Kawakami S, Yatera K, Kawasaki M, Fujita M, Yoshida M, Maeyama T, Harada T, Wataya H, Torii R, Komori M, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Nakanishi Y, Okamoto I. Tsubouchi K, et al. Among authors: tokunaga s. BMJ Open Respir Res. 2023 Nov;10(1):e001864. doi: 10.1136/bmjresp-2023-001864. BMJ Open Respir Res. 2023. PMID: 37963676 Free PMC article.
Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.
Shiota M, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tanegashima T, Tokunaga S, Eto M; SNiP-RCC investigators. Shiota M, et al. Among authors: tokunaga s. Cancer Immunol Immunother. 2023 Jun;72(6):1903-1915. doi: 10.1007/s00262-023-03367-w. Epub 2023 Feb 2. Cancer Immunol Immunother. 2023. PMID: 36729213 Free PMC article.
Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP-RCC study.
Blas L, Shiota M, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tanegashima T, Tokunaga S, Eto M; SNiP-RCC Investigators. Blas L, et al. Among authors: tokunaga s. Int J Urol. 2023 Sep;30(9):788-796. doi: 10.1111/iju.15265. Epub 2023 Aug 1. Int J Urol. 2023. PMID: 37528632
Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failure.
Kuwano A, Okui T, Kohjima M, Kurokawa M, Goya T, Tanaka M, Aoyagi T, Takahashi M, Imoto K, Tashiro S, Suzuki H, Fujita N, Ushijima Y, Ishigami K, Tokunaga S, Kato M, Ogawa Y. Kuwano A, et al. Among authors: tokunaga s. Medicine (Baltimore). 2023 Mar 10;102(10):e33090. doi: 10.1097/MD.0000000000033090. Medicine (Baltimore). 2023. PMID: 36897684 Free PMC article.
RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307).
Saeki H, Jogo T, Kawazoe T, Kamori T, Nakaji Y, Zaitsu Y, Fujiwara M, Baba Y, Nakamura T, Iwata N, Egashira A, Nakanoko T, Morita M, Tanaka Y, Kimura Y, Shibata T, Nakashima Y, Emi Y, Makiyama A, Oki E, Tokunaga S, Shimokawa M, Mori M; Kyushu Study Group of Clinical Cancer (KSCC). Saeki H, et al. Among authors: tokunaga s. Ann Surg. 2022 Apr 1;275(4):692-699. doi: 10.1097/SLA.0000000000003975. Ann Surg. 2022. PMID: 32482981
Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry.
Fujiwara T, Kondo M, Yamada H, Haraguchi A, Fujimura K, Sakuraba K, Kamura S, Fukushi JI, Miyahara H, Inoue Y, Tsuru T, Shuto T, Yoshizawa S, Suematsu E, Miyamura T, Ayano M, Mitoma H, Arinobu Y, Niiro H, Ohishi M, Hirata A, Tokunaga S, Takada A, Hara D, Tsushima H, Akasaki Y, Ikemura S, Sueishi T, Toya M, Sakuragi T, Tsutsui T, Kai K, Arisumi S, Nakashima Y. Fujiwara T, et al. Among authors: tokunaga s. Arthritis Res Ther. 2022 Feb 22;24(1):53. doi: 10.1186/s13075-022-02746-5. Arthritis Res Ther. 2022. PMID: 35193646 Free PMC article.
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.
Tsuda M, Hirata A, Tokunaga S, Masuda T, Haji S, Kimura D, Nojiri C, Nakashima Y, Shiratsuchi M, Kato K, Miyamoto T, Akashi K, Nakashima N, Ogawa Y. Tsuda M, et al. Among authors: tokunaga s. Int J Hematol. 2022 Dec;116(6):863-870. doi: 10.1007/s12185-022-03433-6. Epub 2022 Aug 6. Int J Hematol. 2022. PMID: 35932399
A prospective observational study of postoperative adjuvant chemotherapy for non-small cell lung cancer in elderly patients (≥ 75 years).
Yano T, Hamatake M, Tokunaga S, Okamoto T, Yamazaki K, Miura T, Nagayasu T, Sato M, Fukuyama S, Sugio K; Lung Oncology Group in Kyushu (LOGIK). Yano T, et al. Among authors: tokunaga s. Int J Clin Oncol. 2022 May;27(5):882-888. doi: 10.1007/s10147-022-02143-7. Epub 2022 Feb 25. Int J Clin Oncol. 2022. PMID: 35212829
Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911L.
Akamatsu H, Murakami H, Harada H, Shimizu J, Hayashi H, Daga H, Hasegawa Y, Kim YH, Kato T, Tokunaga S, Nishimura Y, Yamamoto N, Nakagawa K. Akamatsu H, et al. Among authors: tokunaga s. J Thorac Oncol. 2021 Oct;16(10):1745-1752. doi: 10.1016/j.jtho.2021.05.019. Epub 2021 Jun 9. J Thorac Oncol. 2021. PMID: 34116229 Free article.
100 results